Beijing Tongrentang Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Beijing Tongrentang yıllık ortalama 14.2% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 9% annual. Gelirler growing yılda ortalama 8.4% oranında artmaktadır. Beijing Tongrentang'in özkaynak karlılığı 11.7% ve net marjı 9.1%'dir.

Anahtar bilgiler

14.2%

Kazanç büyüme oranı

14.2%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi	10.9%
Gelir büyüme oranı	8.4%
Özkaynak getirisi	11.7%
Net Marj	9.1%
Sonraki Kazanç Güncellemesi	08 Nov 2024

Yakın geçmiş performans güncellemeleri

Beijing Tongrentang's (SHSE:600085) Profits May Not Reveal Underlying Issues

Sep 06

Recent updates

Beijing Tongrentang's (SHSE:600085) Profits May Not Reveal Underlying Issues

Sep 06

Earnings Miss: Beijing Tongrentang Co., Ltd Missed EPS By 20% And Analysts Are Revising Their Forecasts

Sep 03

Here's Why Beijing Tongrentang (SHSE:600085) Has Caught The Eye Of Investors

Aug 17

Is Beijing Tongrentang (SHSE:600085) Using Too Much Debt?

Jul 15

Beijing Tongrentang Co., Ltd (SHSE:600085) Shares Could Be 21% Below Their Intrinsic Value Estimate

Jun 09

Unpleasant Surprises Could Be In Store For Beijing Tongrentang Co., Ltd's (SHSE:600085) Shares

Apr 16

If EPS Growth Is Important To You, Beijing Tongrentang (SHSE:600085) Presents An Opportunity

Mar 31

Beijing Tongrentang (SHSE:600085) Seems To Use Debt Rather Sparingly

Feb 29

Gelir ve Gider Dağılımı

Beijing Tongrentang nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

SHSE:600085 Gelir, gider ve kazançlar (CNY Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Sep 24	17,959	1,628	4,893	266
30 Jun 24	17,863	1,703	4,820	268
31 Mar 24	17,985	1,721	4,801	274
31 Dec 23	17,861	1,669	4,931	277
30 Sep 23	18,194	1,815	4,736	254
30 Jun 23	17,626	1,670	4,680	245
31 Mar 23	16,562	1,551	4,572	228
31 Dec 22	15,372	1,427	4,380	215
30 Sep 22	14,820	1,310	4,082	187
30 Jun 22	14,751	1,347	4,099	197
31 Mar 22	14,850	1,309	4,130	191
31 Dec 21	14,603	1,227	4,061	174
30 Sep 21	14,456	1,236	4,039	165
30 Jun 21	14,182	1,175	3,938	139
31 Mar 21	13,502	1,111	3,769	129
31 Dec 20	12,826	1,031	3,727	132
30 Sep 20	12,371	850	3,727	110
30 Jun 20	12,124	805	3,748	105
31 Mar 20	12,396	875	3,862	106
31 Dec 19	13,277	985	3,959	107
30 Sep 19	13,691	1,135	4,103	104
30 Jun 19	14,098	1,156	4,101	106
31 Mar 19	14,455	1,167	4,243	102
31 Dec 18	14,209	1,134	4,179	91
30 Sep 18	14,070	1,048	4,043	107
30 Jun 18	13,644	1,057	3,862	120
31 Mar 18	13,373	1,040	3,741	99
31 Dec 17	13,376	1,017	3,722	91
30 Sep 17	12,978	994	3,678	34
30 Jun 17	12,705	970	3,644	0
31 Mar 17	12,480	965	3,527	0
31 Dec 16	12,091	933	3,455	0
30 Sep 16	11,788	970	3,366	0
30 Jun 16	11,588	949	3,265	0
31 Mar 16	11,106	898	3,115	0
31 Dec 15	10,897	875	3,068	0
30 Sep 15	10,449	848	2,902	0
30 Jun 15	10,190	828	2,824	0
31 Mar 15	9,816	793	2,618	0
31 Dec 14	9,686	764	2,541	0
30 Sep 14	9,281	728	2,367	0
30 Jun 14	9,134	709	2,373	0
31 Mar 14	8,874	677	2,324	0
31 Dec 13	8,715	656	2,304	0

Kaliteli Kazançlar: 600085 yüksek düzeyde nakit dışı kazança sahiptir.

Büyüyen Kar Marjı: 600085 'nin mevcut net kar marjları (9.1%) geçen yılın (10%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 600085 şirketinin kazancı son 5 yılda yılda 14.2% oranında arttı.

Büyüme Hızlandırma: 600085 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: 600085 geçtiğimiz yıl negatif kazanç büyümesine ( -10.3% ) sahipti ve bu da onu Pharmaceuticals sektör ortalamasıyla ( -1.2% ) karşılaştırmayı zorlaştırıyordu.

Özkaynak Getirisi

Yüksek ROE: 600085 'nin Özsermaye Getirisi ( 11.7% ) düşük olarak değerlendiriliyor.

Beijing Tongrentang Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Third quarter 2024 earnings: EPS misses analyst expectations

Beijing Tongrentang Co., Ltd to Report Q3, 2024 Results on Oct 30, 2024

Beijing Tongrentang's (SHSE:600085) Profits May Not Reveal Underlying Issues

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Beijing Tongrentang Co., Ltd to Report First Half, 2024 Results on Aug 31, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Recent updates

Third quarter 2024 earnings: EPS misses analyst expectations

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of CN¥0.50 per share

Beijing Tongrentang Co., Ltd to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 20%

Beijing Tongrentang's (SHSE:600085) Profits May Not Reveal Underlying Issues

Price target decreased by 7.4% to CN¥48.68

Earnings Miss: Beijing Tongrentang Co., Ltd Missed EPS By 20% And Analysts Are Revising Their Forecasts

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Here's Why Beijing Tongrentang (SHSE:600085) Has Caught The Eye Of Investors

Is Beijing Tongrentang (SHSE:600085) Using Too Much Debt?

Beijing Tongrentang Co., Ltd to Report First Half, 2024 Results on Aug 31, 2024

Beijing Tongrentang Co., Ltd (SHSE:600085) Shares Could Be 21% Below Their Intrinsic Value Estimate

Now 21% undervalued

Beijing Tongrentang Co., Ltd, Annual General Meeting, Jun 14, 2024

Now 20% undervalued

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Unpleasant Surprises Could Be In Store For Beijing Tongrentang Co., Ltd's (SHSE:600085) Shares

Price target decreased by 8.1% to CN¥56.45

If EPS Growth Is Important To You, Beijing Tongrentang (SHSE:600085) Presents An Opportunity

Full year 2023 earnings: EPS and revenues miss analyst expectations

Beijing Tongrentang Co., Ltd to Report Q1, 2024 Results on Apr 30, 2024

Beijing Tongrentang (SHSE:600085) Seems To Use Debt Rather Sparingly

Investor sentiment deteriorates as stock falls 17%

Now 24% undervalued after recent price drop

Beijing Tongrentang Co., Ltd to Report Fiscal Year 2023 Results on Mar 29, 2024

Now 20% undervalued after recent price drop

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.25 in 2Q 2022)

Price target increased by 8.1% to CN¥57.57

Full year 2022 earnings: EPS exceeds analyst expectations

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.22 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.22 in 2Q 2021)

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Investor sentiment improved over the past week

Price target increased to CN¥33.93

Price target increased to CN¥31.48

Second quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.18 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.17 in 1Q 2020)

Price target decreased to CN¥27.11

Full year 2020 earnings released: EPS CN¥0.75 (vs CN¥0.72 in FY 2019)

Beijing Tongrentang Co., Ltd to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day low: CN¥24.20

Beijing Tongrentang Co., Ltd(XSSC:600085) dropped from FTSE All-World Index (USD)

New 90-day low: CN¥25.97

Third quarter earnings released

Third-quarter earnings released: Revenue and earnings miss expectations

Beijing Tongrentang Co., Ltd to Report Q3, 2020 Results on Oct 31, 2020

New 90-day low: CN¥26.72

First half earnings released

New 90-day high - CN¥30.68

Beijing Tongrentang Co., Ltd to Report First Half, 2020 Results on Aug 29, 2020

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin